FDA

cosmin4000/iStock via Getty Images Omeros Corporation (NASDAQ:OMER) said on Tuesday that the U.S. FDA has accepted the resubmitted label expansion application for narsoplimab, a treatment for transplant-associated thrombotic microangiopathy, which…

March 6, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Plus Therapeutics, Inc. (Nasdaq:…

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.